Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_assertion type Assertion NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_head.
- NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_assertion description "[The aims of this study were to develop a reliable hepatic metastatic colonic cancer model in mice using the intraportal route for injection, with follow-up by bioluminescence (BLI) and to evaluate the impact of tumor location on tumor antigen direct targeting using radiolabeled anti-CEA (carcinoembryonic antigen) antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_provenance.
- NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_assertion evidence source_evidence_literature NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_provenance.
- NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_assertion SIO_000772 21116205 NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_provenance.
- NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_assertion wasDerivedFrom befree-20150227 NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_provenance.
- NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_assertion wasGeneratedBy ECO_0000203 NP312217.RALovozjQEIUn_qnk-bhtD_UtoYhxmF20qoh5LN-dmNoY130_provenance.